Results 21 to 30 of about 1,094,278 (405)

Rivaroxaban in Peripheral Artery Disease after Revascularization.

New England Journal of Medicine, 2020
BACKGROUND Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain.
Marc P. Bonaca, R. Bauersachs, Sonia S Anand, E. Debus, M. Nehler, M. Patel, F. Fanelli, W. Capell, Lihong Diao, Nicole Jaeger, Connie N. Hess, Á. Pap, J. Kittelson, I. Gudz, L. Mátyás, D. Krievins, R. Diaz, M. Brodmann, E. Muehlhofer, L. Haskell, S. Berkowitz, W. Hiatt   +21 more
semanticscholar   +1 more source

Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease

Diabetes, obesity and metabolism, 2022
To evaluate the cardiovascular (CV) efficacy of liraglutide and semaglutide in patients with type 2 diabetes (T2D) and peripheral artery disease (PAD).
S. Verma, M. Al-Omran, Lawrence A Leiter, C. Mazer, S. Rasmussen, H. A. Saevereid, M. Ripa, M. Bonaca   +7 more
semanticscholar   +1 more source

An unusual case of isolated symmetric bilateral peripheral artery disease of the radial artery of the index finger in systemic sclerosis: A case report and literature review

Journal of the Practice of Cardiovascular Sciences, 2022
We report an extremely rare and peculiar case of symmetric peripheral small-vessel disease involving only the radial artery of the index finger sparing major vessels in an 80-year-old female with systemic sclerosis (SSc). Our case is the first literature
Debasish Das, Anindya Banerjee, Abhinav Kumar, Shashikant Singh, Subhas Pramanik   +4 more
doaj   +1 more source

Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial decreased major adverse cardiovascular events with very low‐dose rivaroxaban and aspirin in patients with coronary artery disease and peripheral artery ...
Maya S. Sheth, Bing Yu, Anna Chu, Joan Porter, Derrick Y Tam, Laura E. Ferreira‐Legere, Shaun G. Goodman, Michael E. Farkouh, Dennis T. Ko, Husam Abdel‐Qadir, Jacob A. Udell   +10 more
doaj   +1 more source

Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease

Frontiers in Cardiovascular Medicine, 2022
Peripheral artery disease (PAD) is caused by occluded or narrowed arteries that reduce blood flow to the lower limbs. The treatment focuses on lifestyle changes, management of modifiable risk factors and vascular surgery.
M. Kavurma, C. Bursill, Christopher P. Stanley, F. Passam, S. Cartland, Sanjay Patel, Jacky Loa, G. Figtree, J. Golledge, Sarah J Aitken, David A. Robinson   +10 more
semanticscholar   +1 more source

Advances in Revascularization for Peripheral Artery Disease

Circulation Research, 2021
Effective revascularization of the patient with peripheral artery disease is about more than the procedure. The approach to the patient with symptom-limiting intermittent claudication or limb-threatening ischemia begins with understanding the population ...
J. Beckman, P. Schneider, M. Conte
semanticscholar   +1 more source

Peripheral arterial disease.

BMJ clinical evidence, 2009
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for people with chronic peripheral arterial disease? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2009.
Alexander J. Hills, A.C. Shepherd, Alun H. Davies, Joseph Shalhoub   +3 more
openaire   +8 more sources

Racial and Ethnic Disparities in Peripheral Artery Disease

Circulation Research, 2021
Peripheral artery disease is an obstructive, atherosclerotic disease of the lower extremities causing significant morbidity and mortality. Black Americans are disproportionately affected by this disease while they are also less likely to be diagnosed and
Eddie L Hackler, N. Hamburg, Khendi T. White Solaru   +2 more
semanticscholar   +1 more source

Contemporary Medical Management of Peripheral Artery Disease

Circulation Research, 2021
Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis. Modifiable risk factors including cigarette smoking, dyslipidemia, diabetes, poor diet quality, obesity, and physical inactivity, along with underlying genetic factors ...
M. Bonaca, N. Hamburg, M. Creager
semanticscholar   +1 more source

P111 ASSOCIATION AND CLINICAL RELEVANCE OF ABSENCE OF LOWER LIMB ARTERIAL PULSE AND CORONARY ARTERY DISEASE IN HEMODIALYSIS PATIENTS

Artery Research, 2017
Objectives: To determine the association between PAD and DAC in patients treated by haemodialysis in the waiting list for renal transplantation and to assert the influence of that association on prognosis and clinical management.
Luiz Bortolotto, Felizardo Nataniel, Luis Gowdak, Henrique Muela, Flavio Paula, Elias David-Neto, Jose Jayme De Lima   +6 more
doaj   +1 more source